The prospect of targeting lipid metabolism with new therapeutics has gained much momentum in recent times. The key to realizing this goal will be an improved understanding of lipid metabolism (biosynthesis and catabolism), both in the response to disease and of pathogenic organisms. Such information will aid the potential development of effective novel therapeutics.

We invite authors to submit original research and review articles that seek to improve the understanding of lipid metabolism in diseases or pathogens.

We are especially interested in articles that explore the possibility of exploiting this knowledge of lipid metabolism for future translational purposes, that is, diagnosis or treatment. Potential topics include, but are not limited to:

• Lipid metabolism (biosynthesis and catabolism) as it pertains to infectious, genetic, or cancerous diseases. This includes fatty acids, phospholipids, sphingolipids, neutral lipids, glycolipids, lipid signaling molecules, and sterols
• Diseases that relate to humans (i.e., cancer, diabetes, obesity, cardiovascular disease, and diseases of the brain), animals, or plants
• Infectious agents, including viruses, pathogenic bacteria, pathogenic fungi, eukaryotic parasites, and other pathogens and pests
• Lipidomic studies of pathogens
• Genetic and/or chemical validation of enzymes directly or indirectly involved in lipid metabolism and disease

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/bcri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable: